204 related articles for article (PubMed ID: 37698887)
1. Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme.
Beola L; Iturrioz-Rodríguez N; Pucci C; Bertorelli R; Ciofani G
ACS Nano; 2023 Sep; 17(18):18441-18455. PubMed ID: 37698887
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment.
Marino A; Camponovo A; Degl'Innocenti A; Bartolucci M; Tapeinos C; Martinelli C; De Pasquale D; Santoro F; Mollo V; Arai S; Suzuki M; Harada Y; Petretto A; Ciofani G
Nanoscale; 2019 Nov; 11(44):21227-21248. PubMed ID: 31663592
[TBL] [Abstract][Full Text] [Related]
3. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy.
Tapeinos C; Marino A; Battaglini M; Migliorin S; Brescia R; Scarpellini A; De Julián Fernández C; Prato M; Drago F; Ciofani G
Nanoscale; 2018 Dec; 11(1):72-88. PubMed ID: 30357214
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of glioblastoma cancer cells to radiotherapy and magnetic hyperthermia by targeted temozolomide-loaded magnetite tri-block copolymer nanoparticles as a nanotheranostic agent.
Minaei SE; Khoei S; Khoee S; Mahdavi SR
Life Sci; 2022 Oct; 306():120729. PubMed ID: 35753439
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
7. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U
ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155
[TBL] [Abstract][Full Text] [Related]
8. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
11. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
Kim SS; Rait A; Kim E; Pirollo KF; Chang EH
Nanomedicine; 2015 Feb; 11(2):301-11. PubMed ID: 25240597
[TBL] [Abstract][Full Text] [Related]
12. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT.
Tsai CK; Huang LC; Wu YP; Kan IY; Hueng DY
FASEB J; 2019 Dec; 33(12):14171-14184. PubMed ID: 31725331
[TBL] [Abstract][Full Text] [Related]
13. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
[TBL] [Abstract][Full Text] [Related]
14. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
Fadera S; Chen PY; Liu HL; Lee IC
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
Yu Y; Wang A; Wang S; Sun Y; Chu L; Zhou L; Yang X; Liu X; Sha C; Sun K; Xu L
Mol Pharm; 2022 Apr; 19(4):1219-1229. PubMed ID: 35262365
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma.
Fu W; You C; Ma L; Li H; Ju Y; Guo X; Shi S; Zhang T; Zhou R; Lin Y
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39525-39533. PubMed ID: 31601097
[TBL] [Abstract][Full Text] [Related]
17. Loco-regional treatment with temozolomide-loaded thermogels prevents glioblastoma recurrences in orthotopic human xenograft models.
Gherardini L; Vetri Buratti V; Maturi M; Inzalaco G; Locatelli E; Sambri L; Gargiulo S; Barone V; Bonente D; Bertelli E; Tortorella S; Franci L; Fioravanti A; Comes Franchini M; Chiariello M
Sci Rep; 2023 Mar; 13(1):4630. PubMed ID: 36944737
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.
Yang TC; Liu SJ; Lo WL; Chen SM; Tang YL; Tseng YY
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074038
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488
[TBL] [Abstract][Full Text] [Related]
20. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
Kim JS; Shin DH; Kim JS
J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]